eMeasure Title Prophylactic Antibiotic Selection for Surgical Patients
eMeasure Identifier
(Measure Authoring Tool)
172 eMeasure Version number 4
NQF Number 0528 GUID feea3922-f61f-4b05-98f9-b72a11815f12
Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward Centers for Medicare & Medicaid Services
Measure Developer Oklahoma Foundation for Medical Quality
Endorsed By National Quality Forum
Description
Surgical patients who received prophylactic antibiotics consistent with current guidelines (specific to each type of surgical procedure).
Copyright
Measure specifications are in the Public Domain

LOINC(R) is a registered trademark of the Regenstrief Institute.

This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2010 International Health Terminology Standards Development Organization. All rights reserved.
Disclaimer
None
Measure Scoring Proportion
Measure Type Process
Stratification
None
Risk Adjustment
None
Rate Aggregation
None
Rationale
A goal of prophylaxis with antibiotics is to use an agent that is safe, cost-effective, and has a spectrum of action that covers most of the probable intraoperative contaminants for the operation. First or second-generation cephalosporins satisfy these criteria for most operations, although anaerobic coverage is needed for colon surgery. Vancomycin is not recommended for routine use because of the potential for development of antibiotic resistance, but is acceptable if a patient is allergic to beta-lactams, as are fluoroquinolones and clindamycin in selected situations.
Clinical Recommendation Statement
National guidelines recommend specific classes of antibiotics for surgical procedures. First or second-generation cephalosporins satisfy the criteria (safe, cost-effective, and coverage for most probable contaminants) for most operations, although anaerobic coverage is needed for colon surgery.
Improvement Notation
Higher score indicates better quality.
Reference
Bratzler DW, Houck PM, for the Surgical Infection Prevention Guidelines Writers Group. Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. CID. 2004:38(15 June):1706-1715.
Reference
Mangram AJ, Horan TC, Pearson ML, et al. Guidelines for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:247-280.
Reference
American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999;56:1839-1888.
Reference
No author listed. The Medical letter.  Antimicrobial prophylaxis for Surgery. Med Lett Drugs Ther. 2009; 82: 47-52.
Reference
Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis. 1994;18:422-427.
Reference
Gilbert DN, Moellering RC Jr., Elipoulos GM, Chamber HF, Saag MS, eds. The Sanford Guide to Antimicrobial Therapy  2009. 39st ed. Sperryville, VA: Antimicrobial Therapy, Inc; 2009.
Reference
Itani KMF, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med. 2006 Dec 21; 355 (25): 2640-2651.
Reference
Page CP, Bohnen JM, Fletcher JR, et al. Antimicrobial prophylaxis for surgical wounds. Arch Surg. 1993;128:79-88.
Reference
American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins ACOG Practice Bulletin No 104 Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol May 2009; 113(5) : 1180-1189.
Reference
Bratzler DW, Houck PM, for the Surgical Infection Prevention Guidelines Writers Group. Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. CID. 2004:38(15 June):1706-1715.
Definition
None
Guidance
The measurement period is one calendar year but the reporting period is 3 months as a calendar quarter; Q1 = Jan – Mar, Q2 = Apr – Jun, Q3 = Jul – Sep, Q4 is Oct – Dec.

Denominator Exclusion guidance:

The exclusion for patients who are clinical trial participants is limited to patients participating in a clinical trial for the same conditions as covered by the measure. Other clinical trials are not valid reasons for exclusions.

Numerator element guidance:

Vancomycin is acceptable for CABG, other cardiac procedures, hip arthroplasty, knee arthroplasty and vascular surgery if there is an increased MRSA rate facility-wide or operation-specific. For the purpose of using vancomycin for prophylaxis, it is expected that vancomycin is given ONLY if one of the allowable conditions is TRUE.
Transmission Format
None
Initial Patient Population
All hospital discharges for selective surgery with hospital stays <= 120 days during the measurement year for patients age 18 and older at the time of hospital admission with no evidence of prior infection.
The measure is divided into 8 populations by type of surgery. Each denominator provides criteria for the types of surgery.
Denominator
All selected surgical patients 18 years of age and older with no evidence of prior infection with a Principal Procedure Code of selected surgeries.
Denominator for population 1 - Coronary artery bypass graft (CABG) procedures
Denominator for population 2 - Other cardiac surgery
Denominator for population 3 - Hip arthroplasty
Denominator for population 4 - Knee arthroplasty
Denominator for population 5 - Colon surgery
Denominator for population 6 - Abdominal hysterectomy
Denominator for population 7 - Vaginal hysterectomy
Denominator for population 8 - Vascular surgery
Denominator Exclusions
•	Patients who had a principal diagnosis suggestive of preoperative infectious diseases 
•	Patients enrolled in clinical trials-this exclusion is limited to patients participating in a clinical trial for the same conditions as covered by the measure.  Other clinical trials are not valid reasons for exclusion.
•	Patients whose principal procedure occurred prior to the date of admission
•	Patients with physician/advanced practice nurse/physician assistant (physician/APN/PA) documented infection prior to surgical procedure of interest
•	Patients who expired perioperatively
•	Patients who had other procedures requiring general or spinal anesthesia that occurred within 3 days (4 days for CABG or Other Cardiac Surgery) prior to or after the procedure of interest (during separate surgical episodes) during this hospital stay
•	Patients who did not receive any antibiotics within the timeframe 24 hours before Surgical Incision Date and Time (i.e., patient did not receive prophylactic antibiotics) through discharge
•	Patients who received antibiotics prior to arrival and did not receive any antibiotics during this hospitalization 
•	Patients who received ONLY oral or intramuscular (IM) antibiotics or the route was unable to be determined 
•	Patients who received ALL antibiotics greater than 1440 minutes prior to Surgical Incision Date and Time
Numerator
Number of surgical patients who received prophylactic antibiotics recommended for their specific surgical procedure.
Numerator Exclusions
Not applicable
Denominator Exceptions
None
Measure Population
Not applicable.
Measure Observations
Not applicable.
Supplemental Data Elements
For every patient evaluated by this measure also identify payer, race, ethnicity, and sex.

Table of Contents


Population criteria

      ------ Population Criteria 1 ------

      ------ Population Criteria 2 ------

      ------ Population Criteria 3 ------

      ------ Population Criteria 4 ------

      ------ Population Criteria 5 ------

      ------ Population Criteria 6 ------

      ------ Population Criteria 7 ------

      ------ Population Criteria 8 ------

Data criteria (QDM Data Elements)

Reporting Stratification

Supplemental Data Elements




Measure Set
Surgical Care Improvement Project